World-first immunotherapy trial to treat type 1 diabetes
Researchers at the University of Queensland have initiated a groundbreaking clinical trial to evaluate ASITI-201, an investigational immunotherapy designed to treat type 1 diabetes (T1D). Developed under the leadership of Professor Ranjeny Thomas, ASITI-201 combines a pancreatic protein with vitamin D to modulate the immune system, aiming to protect insulin-producing beta cells from autoimmune destruction. […]
